Abstract:Abstract Background High-risk neuroblastoma, as a lethal pediatric tumor, has unfavorable clinical outcomes, and accounts for ~15% of childhood cancer‐related mortality. However, the biomarkers for treatment prognosis have remained largely elusive. The present study sought to identify potential genes associated with the progression and prognosis of high-risk neuroblastoma. Methods The gene expression profiles of neuroblastoma were downloaded from the Gene Expression omnibus (GEO) database, and samples from GSE62564 and GSE16476 were applied as the training set and validation set, respectively. Bioinformatic analysis were performed by R. Subsequently, the biological functions of key gene were investigated by transwell, western blot, and flow cytometry analysis. miRNA that regulated the expression of key gene were predicted and the bind site were validated by luciferase reporter analysis and Q-PCR in children with high-risk neuroblastoma. Results Analysis shown that 120 differentially expressed genes (DEGs) in the blue module were identified to be significantly related to high-risk neuroblastoma by weighted correlation network analysis (WGCNA). After MCODE and Cytohubba algorithm analyses, 26 genes were recognized as hub genes. Subsequently, univariate COX and LASSO regression analyses identified a six-gene signature (NCAPG, UBE2C, MELK, CCNA2, KIF15, and BIRC5) and constructed a prognostic model. The expression of these six genes in high-risk neuroblastoma children was significantly higher than that in non-high-risk neuroblastoma children. These signature genes and the prognostic model demonstrated strong prognostic capability using Kaplan-Meier (KM) curves. Subsequently, NCAPG was selected as key gene and the results indicated that knockdown NCAPG suppressed the migration and invasion, increased the apoptosis rate and decreased the Bcl-2 level in neuroblastoma cells. In addition, the luciferase reporter analysis method showed that miR-495-3p can negatively regulate the expression of NCAPG. Q-PCR indicated that miR-495-3p highly expressed in children with high-risk neuroblastoma. Conclusion Our findings identified that miR-495-3p/ NCAPG could serve as prognostic biomarkers of high-risk neuroblastoma and may advance the understanding of the molecular pathogenesis.

NCAPG Promotes Tumor Progression and Modulates Immune Cell Infiltration in Glioma

NCAPG as a Novel Prognostic Biomarker in Glioma

Integrative Analysis Reveals the Potential Prognostic Roles and Immunological Values of Unc-5 Netrin Receptor A (UNC5A) in Glioma

NCAPG is a Promising Therapeutic Target Across Different Tumor Types

NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway

A Novel Classifier Combining G Protein-Coupled Receptors and the Tumor Microenvironment is Associated with Survival Status in Glioblastoma.

NCAPH serves as a prognostic factor and promotes the tumor progression in glioma through PI3K/AKT signaling pathway

NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression

NCAPG2 Could Be an Immunological and Prognostic Biomarker: from Pan-Cancer Analysis to Pancreatic Cancer Validation

Identification of NCAPG as an Essential Gene for Neuroblastoma Employing CRISPR-Cas9 Screening Database and Experimental Verification

Actin-capping Protein CapG is Associated with Prognosis, Proliferation and Metastasis in Human Glioma

NCAPG is a Potential Biomarker for Prognosis of Treatment in Children with High-risk Neuroblastoma

NCAPG2 Promotes Tumour Proliferation by Regulating G2/M Phase and Associates with Poor Prognosis in Lung Adenocarcinoma

NCAPG2 facilitates glioblastoma cells’ malignancy and xenograft tumor growth via HBO1 activation by phosphorylation

The role of NCAPG in various of tumors

NCAPG promotes proliferation of epithelial ovarian cancer by activating the NF-κB and AKT/mTOR pathways

Natural Killer Cell-Related Gene Signature Predicts Malignancy of Glioma and the Survival of Patients

Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma

MGCG Regulates Glioblastoma Tumorigenicity Via Hnrnpk/atg2a and Promotes Autophagy

Pan-cancer Analysis of GALNTs Expression Identifies a Prognostic of GALNTs Feature in Low Grade Glioma

Genome-wide CRISPR Knockout Screens Identify NCAPG As an Essential Oncogene for Hepatocellular Carcinoma Tumor Growth